{"id":"W4292121937","doi":"10.1007/s00432-022-04189-6","title":"Triple negative breast cancer: approved treatment options and their mechanisms of action","year":2022,"lang":"en","type":"article","venue":"Journal of Cancer Research and Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Triple-negative breast cancer; Epirubicin; Olaparib; Breast cancer; Oncology; Docetaxel; Paclitaxel; Internal medicine; Adverse effect; Cancer; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007495625,0.0003995674,0.000594306,0.0008703554,0.0002737509,0.0009323179,0.0006285306,0.0007115629,0.006739516],"category_scores_gemma":[0.0008954045,0.0001542707,0.0004704068,0.0007616745,0.0003369396,0.0009292698,0.0004612149,0.001386191,0.001550349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006552428,"about_ca_system_score_gemma":0.000958527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006564936,"about_ca_topic_score_gemma":0.001867046,"domain_scores_codex":[0.9996735,0.00008323661,0.00004046517,0.0000457641,0.0001234175,0.00003359826],"domain_scores_gemma":[0.9996623,0.00008963468,0.00007320159,0.00001063448,0.0001348606,0.0000293365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003222811,0.0001124679,0.0005490239,0.01320484,0.000114882,0.0003915815,0.0001064269,0.0003555624,0.004557273,0.009384982,0.05901333,0.9118873],"study_design_scores_gemma":[0.00007470955,0.0003358192,0.0009535263,0.004622443,0.0001897231,0.001363788,0.00008545243,0.0001374057,0.001250919,0.0029068,0.9880586,0.000020952],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000950569,0.9907755,0.0003146441,0.002223055,0.0004491866,0.0000201317,0.000152305,0.00002216376,0.005092405],"genre_scores_gemma":[0.008695972,0.9854731,0.000751175,0.001958481,0.0005287147,0.00004490031,0.000302573,0.000007444626,0.002237781],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006739516,"threshold_uncertainty_score":0.02254599,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3171317950564267,"score_gpt":0.5861197862775303,"score_spread":0.2689879912211036,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}